Hallis K F, Boon N A, Perkins C M, Aronson J K, Grahame-Smith D G
Clin Chem. 1985 Feb;31(2):274-6.
This method for determination of Rb+ in human plasma and erythrocytes by graphite-furnace atomic absorption spectrophotometry has a sensitivity of 29 nmol/L for plasma, 12 nmol/L for erythrocytes. The detection limit is 24 nmol/L for plasma, 4.8 nmol/L for erythrocytes. This assay is approximately 30-fold more sensitive than previously reported techniques involving atomic absorption spectrophotometry, enabling use of smaller samples. The rubidium signal is linear with concentration up to 1.2 mumol/L, and addition of other cations to the matrix produces only minor alterations in the Rb+ signal. We measured plasma and erythrocytic Rb+ concentrations in healthy subjects and in patients with untreated essential hypertension. In both, our values are similar to those previously reported for healthy individuals.
这种采用石墨炉原子吸收分光光度法测定人体血浆和红细胞中铷离子的方法,对血浆的灵敏度为29纳摩尔/升,对红细胞为12纳摩尔/升。血浆的检测限为24纳摩尔/升,红细胞为4.8纳摩尔/升。该检测方法的灵敏度比先前报道的涉及原子吸收分光光度法的技术高约30倍,从而能够使用更小的样本。铷信号在浓度高达1.2微摩尔/升时呈线性,向基质中添加其他阳离子只会使铷离子信号产生微小变化。我们测量了健康受试者和未经治疗的原发性高血压患者的血浆和红细胞铷离子浓度。在这两组人群中,我们测得的值与先前报道的健康个体的值相似。